Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Total Current Liabilities (2022 - 2025)

CervoMed (CRVO) has disclosed Total Current Liabilities for 8 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 20.03% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, up 20.03% year-over-year, with the annual reading at $4.7 million for FY2025, 20.03% up from the prior year.
  • Total Current Liabilities hit $4.7 million in Q4 2025 for CervoMed, up from $3.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.7 million in Q4 2025 to a low of $2.3 million in Q3 2022.
  • Historically, Total Current Liabilities has averaged $3.3 million across 3 years, with a median of $3.0 million in 2022.
  • Biggest YoY gain for Total Current Liabilities was 20.03% in 2025; the steepest drop was 20.03% in 2025.
  • Year by year, Total Current Liabilities stood at $2.3 million in 2022, then soared by 70.84% to $3.9 million in 2024, then increased by 20.03% to $4.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for CRVO at $4.7 million in Q4 2025, $3.9 million in Q4 2024, and $2.3 million in Q3 2022.